Compare VTGN & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTGN | MSN |
|---|---|---|
| Founded | 1998 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 10.2M |
| IPO Year | 2014 | 1995 |
| Metric | VTGN | MSN |
|---|---|---|
| Price | $0.24 | $0.50 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $0.90 | N/A |
| AVG Volume (30 Days) | ★ 716.8K | 338.9K |
| Earning Date | 06-16-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $77,829,000.00 |
| Revenue This Year | $124.49 | N/A |
| Revenue Next Year | $353.99 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.20 | $0.34 |
| 52 Week High | $5.14 | $0.85 |
| Indicator | VTGN | MSN |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 68.73 |
| Support Level | $0.23 | $0.36 |
| Resistance Level | $0.32 | N/A |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 31.67 | 78.88 |
Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.
Emerson Radio Corp designs, sources, imports, markets, sells and licenses to certain licensees a variety of houseware and consumer electronic products, both domestically and internationally, under the Emerson brand name. The Company's core business consists of selling, distributing, and licensing various low and moderately priced houseware and consumer electronic products in various categories. Its products are Houseware Products consist Microwave Ovens, Compact Refrigerators, Toaster Ovens, Heaters and Fans; Audio Products consist Clock Radios, Bluetooth Speakers, Karaoke Machines, Wireless Charging; and Other consist Televisions, Security Products, Massagers. It operates in One segment. Majority of revenue comes from United States.